Biopharmaceutical Contract Manufacturing Market Scope And Analysis

  • Report Code : TIPRE00005512
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 211
Buy Now

Biopharmaceutical Contract Manufacturing Market Analysis 2031

Buy Now

Biopharmaceutical Contract Manufacturing Market Report Biopharmaceutical Contract Manufacturing Market Size and Share Biopharmaceutical Contract Manufacturing Market Scope and Analysis

Biopharmaceutical Contract Manufacturing Market Report Scope

Report Attribute Details
Market size in 2021 US$ 15.74 Billion
Market Size by 2028 US$ 27.87 Billion
Global CAGR (2021 - 2028) 8.5%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product
  • Biologics and Biosimilar
By Service
  • Process Development
  • Fill and Finish Operations
  • Analytical and Quality Control Studies
  • Packaging
By Source
  • Mammalian and Microbial-Based Biologics/Non-Mammalian
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Lonza AG
  • Boehringer Ingelheim Biopharmaceuticals GmbH
  • Inno Bio Ventures Sdn Bhd
  • Thermo Fisher Scientific Inc
  • AbbVie Inc
  • WuXi Biologics Inc
  • General Electric Co
  • Samsung Biologics Co Ltd
  • Merck KGaA